Austrian Science Fund (FWF)

Psychology & Psychiatry

Sex differences in cognitive regulation of stress

While it is true that women and men respond differently to stress, current neuroscientific research only partially confirms traditional gender stereotypes. Other factors heavily contribute to the stress response such as self-esteem, ...

Neuroscience

Neuropeptide may aid targeted anxiety therapy

The targeted control of biochemical processes and neuronal signalling pathways using the messenger substance neuropeptide Y could help in the future treatment of anxiety disorders. This is demonstrated in research findings ...

Alzheimer's disease & dementia

Optimised long-term care for persons with dementia

Life expectancy is rising – as is the need for professional long-term care. The care services currently being provided barely meet the existing demand. Therefore, the available resources need to be adapted intelligently. ...

HIV & AIDS

New insights into latent HIV infections

In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. ...

Psychology & Psychiatry

Study finds no lithium prescription residues in drinking water

Studies show that lithium contained in drinking water lowers suicide rates. This still holds true when taking account of drug residues of lithium prescriptions, as has been shown by a current study for Austria within the ...

Parkinson's & Movement disorders

Parkinson's vaccine – clinical results boost prospects

AFFiRiS AG announced today results of AFF008A, a Phase I clinical trial to assess boost immunizations with AFFITOPE PD01A, an active vaccine against Parkinson's disease (PD). The study was funded by a $1.04 million grant ...

Diseases, Conditions, Syndromes

Leading chikungunya vaccine in clinical trial phase 2

With the first patient vaccinated, a phase 2 clinical trial of a promising prophylactic vaccine candidate against Chikungunya fever has now commenced. The product is the most advanced Chikungunya vaccine candidate globally ...

page 2 from 5